Fukae M - Search Results

1

Bayesian sparse regression for exposure-response analyses of efficacy and safety endpoints to justify the clinical dose of valemetostat for adult T-cell leukemia/lymphoma.

Fukae M, Rogers J, Garcia R, Tachibana M, Shimizu T. Fukae M, et al. CPT Pharmacometrics Syst Pharmacol. 2024 Oct;13(10):1655-1669. doi: 10.1002/psp4.13203. Epub 2024 Aug 18. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 39155584 Free PMC article.

2

Population pharmacokinetics of total and unbound valemetostat and platelet dynamics in healthy volunteers and patients with non-Hodgkin lymphoma.

Fukae M, Baron K, Tachibana M, Mondick J, Shimizu T. Fukae M, et al. CPT Pharmacometrics Syst Pharmacol. 2024 Oct;13(10):1641-1654. doi: 10.1002/psp4.13201. Epub 2024 Jul 30. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 39077926 Free PMC article.

3

Exposure-response analysis of the efficacy and safety of esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with or without diabetic kidney disease.

Yoshihara K, Fukae M, Kastrissios H, Wada R, Shimizu T. Yoshihara K, et al. Among authors: fukae m. Drug Metab Pharmacokinet. 2024 Apr;55:100535. doi: 10.1016/j.dmpk.2023.100535. Epub 2023 Oct 19. Drug Metab Pharmacokinet. 2024. PMID: 38245949 Free article.

4

Population pharmacokinetics of esaxerenone, a novel non-steroidal mineralocorticoid receptor blocker, in patients with essential hypertension, patients with diabetic nephropathy, and healthy volunteers.

Yoshihara K, Fukae M, Kastrissios H, Wada R, Shimizu T, Ishizuka H. Yoshihara K, et al. Among authors: fukae m. Drug Metab Pharmacokinet. 2023 Oct;52:100516. doi: 10.1016/j.dmpk.2023.100516. Epub 2023 Jun 7. Drug Metab Pharmacokinet. 2023. PMID: 37690271 Free article.

5

Safety, Tolerability, and Pharmacokinetics of Valemetostat Tablets and the Effect of Food on Valemetostat Pharmacokinetics in Healthy Subjects: Two Phase 1 Studies.

Tachibana M, Matsuki S, Toyama K, Maekawa Y, Fukae M, Shimizu T, Tsutsumi J, Shinohara S, Ishizuka H. Tachibana M, et al. Among authors: fukae m. Clin Pharmacol Drug Dev. 2024 Jan;13(1):77-86. doi: 10.1002/cpdd.1315. Epub 2023 Aug 11. Clin Pharmacol Drug Dev. 2024. PMID: 37565616 Clinical Trial.

6

Trastuzumab Deruxtecan Dosing in Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer: Population Pharmacokinetic Modeling and Exposure-Response Analysis.

Yoshihara K, Kobayashi Y, Endo S, Fukae M, Hennig S, Kastrissios H, Kamiyama E, Garimella T, Abutarif M. Yoshihara K, et al. Among authors: fukae m. J Clin Pharmacol. 2023 Nov;63(11):1232-1243. doi: 10.1002/jcph.2295. Epub 2023 Jul 12. J Clin Pharmacol. 2023. PMID: 37393579

7

Calculation of Human Melatonin Partial Metabolic Clearance in Healthy Adult Volunteers for Investigation of a Novel in Vivo CYP1A2 Phenotyping Method: A Pilot Study.

Ohki S, Ogawa S, Takano H, Shimazaki H, Fukae M, Furihata T, Shibasaki H, Yokokawa A. Ohki S, et al. Among authors: fukae m. Biol Pharm Bull. 2023;46(5):736-740. doi: 10.1248/bpb.b22-00885. Biol Pharm Bull. 2023. PMID: 37121701 Free article.

8

Characterization of changes in HbA1c in patients with and without secondary failure after metformin treatments by a population pharmacodynamic analysis using mixture models.

Tamaki Y, Maema K, Kakara M, Fukae M, Kinoshita R, Kashihara Y, Muraki S, Hirota T, Ieiri I. Tamaki Y, et al. Among authors: fukae m. Drug Metab Pharmacokinet. 2018 Dec;33(6):264-269. doi: 10.1016/j.dmpk.2018.08.002. Epub 2018 Aug 16. Drug Metab Pharmacokinet. 2018. PMID: 30360949

9

Safety, Tolerability, and Pharmacokinetics of NK-104-NP.

Nakano K, Matoba T, Koga JI, Kashihara Y, Fukae M, Ieiri I, Shiramoto M, Irie S, Kishimoto J, Todaka K, Egashira K. Nakano K, et al. Among authors: fukae m. Int Heart J. 2018 Sep 26;59(5):1015-1025. doi: 10.1536/ihj.17-555. Epub 2018 Aug 29. Int Heart J. 2018. PMID: 30158384 Free article. Clinical Trial.

10

Population Pharmacodynamic Analysis of Uric Acid-Lowering Effects of Febuxostat Based on Electronic Medical Records in Two Hospitals.

Muraki S, Moriki K, Shigematsu S, Fukae M, Kakara M, Yamashita D, Hirota T, Takane H, Shimada M, Hirakawa M, Ieiri I. Muraki S, et al. Among authors: fukae m. J Clin Pharmacol. 2018 Mar;58(3):304-313. doi: 10.1002/jcph.1023. Epub 2017 Oct 18. J Clin Pharmacol. 2018. PMID: 29045766

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters